Given the pathological relevance of TDP-43 aggregation in ALS/FTD, we anticipate that the observed synergy between RRM1–2 and (GGGGCC)n repeats bear significance for the aggregation observed in ALS/FTD and may inform the development of future therapeutic strategies. This evidence concerns the gene TARDBP and amyotrophic lateral sclerosis.